A Study to Evaluate the Impact of Activated Charcoal on the Absorption of LY2140023 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2012
At a glance
- Drugs Charcoal; Pomaglumetad methionil
- Indications Schizophrenia
- Focus Pharmacokinetics
- 29 Aug 2012 Status changed from recruiting to discontinued, according to an Eli Lilly media release.
- 26 Jul 2012 Planned end date changed from 1 Jul 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 12 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.